| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.05B | 206.44B | 200.38B | 189.86B | 176.02B | 149.48B |
| Gross Profit | 63.03B | 64.73B | 62.37B | 58.96B | 56.38B | 39.96B |
| EBITDA | 22.99B | 25.75B | 22.35B | 23.79B | 24.40B | 7.42B |
| Net Income | 12.90B | 14.64B | 12.57B | 14.29B | 14.01B | 277.00M |
Balance Sheet | ||||||
| Total Assets | 179.43B | 188.91B | 183.86B | 170.75B | 164.45B | 147.94B |
| Cash, Cash Equivalents and Short-Term Investments | 30.49B | 35.71B | 34.03B | 25.40B | 25.12B | 18.65B |
| Total Debt | 16.18B | 14.53B | 12.78B | 7.48B | 10.45B | 10.10B |
| Total Liabilities | 67.50B | 66.64B | 70.07B | 64.04B | 68.63B | 59.61B |
| Stockholders Equity | 111.23B | 121.55B | 113.04B | 106.69B | 95.81B | 87.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.90B | 14.52B | 8.43B | 14.55B | 3.82B |
| Operating Cash Flow | 0.00 | 14.32B | 19.26B | 12.82B | 17.37B | 5.72B |
| Investing Cash Flow | 0.00 | -4.63B | -6.87B | -1.85B | -408.00M | -827.00M |
| Financing Cash Flow | 0.00 | -8.26B | -3.98B | -11.25B | -9.36B | -13.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
65 Neutral | ¥7.93B | 4.20 | ― | 1.66% | 16.91% | 1710.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥5.03B | 7.41 | ― | 1.76% | 2.04% | 34.04% | |
43 Neutral | ¥8.01B | -5.48 | ― | 2.65% | 1.29% | -181.94% |